Punjab issues stoppage alert for a batch of Glycosting injection
Punjab’s health authorities have ordered an immediate halt to the release, distribution and supply of a batch of Glycosting injection, citing reports of a suspected adverse drug reaction. The Directorate of Drugs Control, Punjab, issued the medicine stoppage alert under Alert No. 125/2026. The affected product is Glycosting 1ml injection, containing glycopyrrolate 0.5mg and neostigmine methylsulfate 2.5mg. The alert identifies the affected batch as BBG11, with an expiry date of January 2028. The authorities said the product had been reported to cause a suspected adverse drug…

